Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ambulatory Care | 1 | 2025 | 81 | 0.870 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2022 | 760 | 0.810 |
Why?
|
| Telemedicine | 2 | 2025 | 234 | 0.760 |
Why?
|
| Diabetes Mellitus | 2 | 2025 | 539 | 0.680 |
Why?
|
| MicroRNAs | 2 | 2026 | 518 | 0.630 |
Why?
|
| Endothelial Cells | 1 | 2022 | 329 | 0.580 |
Why?
|
| Obesity | 5 | 2014 | 1151 | 0.400 |
Why?
|
| Metabolic Diseases | 2 | 2023 | 40 | 0.360 |
Why?
|
| Gene Expression Profiling | 3 | 2026 | 704 | 0.340 |
Why?
|
| Osteoporosis | 2 | 2009 | 45 | 0.340 |
Why?
|
| District of Columbia | 4 | 2025 | 80 | 0.310 |
Why?
|
| Vitamin D Deficiency | 1 | 2011 | 107 | 0.300 |
Why?
|
| Medical Staff, Hospital | 1 | 2009 | 15 | 0.300 |
Why?
|
| Clinical Protocols | 1 | 2009 | 36 | 0.300 |
Why?
|
| Insulin Resistance | 1 | 2011 | 201 | 0.290 |
Why?
|
| Fractures, Bone | 1 | 2009 | 63 | 0.290 |
Why?
|
| Retrospective Studies | 6 | 2025 | 2544 | 0.240 |
Why?
|
| RNA, Untranslated | 1 | 2026 | 50 | 0.230 |
Why?
|
| Hospitals, Urban | 1 | 2025 | 42 | 0.230 |
Why?
|
| Hospitals, Teaching | 1 | 2025 | 33 | 0.230 |
Why?
|
| Sex Factors | 3 | 2025 | 1028 | 0.230 |
Why?
|
| Steroid Metabolism, Inborn Errors | 1 | 2004 | 1 | 0.210 |
Why?
|
| Humans | 24 | 2026 | 43102 | 0.210 |
Why?
|
| Human Growth Hormone | 1 | 2004 | 21 | 0.210 |
Why?
|
| Growth Disorders | 1 | 2004 | 23 | 0.210 |
Why?
|
| Medicare | 3 | 2017 | 332 | 0.210 |
Why?
|
| Adult | 11 | 2026 | 13872 | 0.200 |
Why?
|
| Male | 17 | 2026 | 23409 | 0.200 |
Why?
|
| Pilot Projects | 5 | 2026 | 760 | 0.190 |
Why?
|
| Fatty Liver | 1 | 2023 | 77 | 0.190 |
Why?
|
| Female | 17 | 2026 | 24698 | 0.190 |
Why?
|
| Middle Aged | 10 | 2026 | 12222 | 0.190 |
Why?
|
| Anemia, Sickle Cell | 1 | 2004 | 187 | 0.180 |
Why?
|
| Aged | 7 | 2025 | 8214 | 0.180 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 224 | 0.170 |
Why?
|
| Vitamin D | 2 | 2014 | 196 | 0.160 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2020 | 46 | 0.160 |
Why?
|
| Exosomes | 1 | 2022 | 126 | 0.160 |
Why?
|
| Overweight | 2 | 2014 | 249 | 0.160 |
Why?
|
| Insulin | 5 | 2016 | 258 | 0.150 |
Why?
|
| Environmental Pollutants | 1 | 2020 | 201 | 0.140 |
Why?
|
| Case-Control Studies | 3 | 2026 | 1285 | 0.130 |
Why?
|
| Pharmacies | 1 | 2017 | 23 | 0.130 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 49 | 0.130 |
Why?
|
| Community Pharmacy Services | 1 | 2017 | 25 | 0.130 |
Why?
|
| Body Mass Index | 4 | 2014 | 925 | 0.130 |
Why?
|
| Competitive Bidding | 1 | 2016 | 1 | 0.120 |
Why?
|
| Glucose Tolerance Test | 2 | 2013 | 75 | 0.120 |
Why?
|
| Health Services Needs and Demand | 2 | 2013 | 154 | 0.110 |
Why?
|
| Complementary Therapies | 1 | 2015 | 51 | 0.110 |
Why?
|
| Quality of Health Care | 1 | 2015 | 161 | 0.100 |
Why?
|
| Child | 4 | 2013 | 3443 | 0.100 |
Why?
|
| Leptin | 2 | 2013 | 118 | 0.100 |
Why?
|
| Vitamins | 1 | 2014 | 81 | 0.100 |
Why?
|
| Models, Theoretical | 1 | 2015 | 232 | 0.100 |
Why?
|
| Colonic Polyps | 1 | 2014 | 71 | 0.100 |
Why?
|
| Ghrelin | 1 | 2013 | 17 | 0.100 |
Why?
|
| Adolescent | 5 | 2015 | 6081 | 0.090 |
Why?
|
| C-Peptide | 1 | 2011 | 7 | 0.090 |
Why?
|
| Ideal Body Weight | 1 | 2011 | 3 | 0.090 |
Why?
|
| United States | 6 | 2022 | 5205 | 0.080 |
Why?
|
| Adiponectin | 1 | 2011 | 59 | 0.080 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 1001 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 2853 | 0.080 |
Why?
|
| Patient-Centered Care | 1 | 2011 | 75 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2015 | 497 | 0.080 |
Why?
|
| Nutritional Status | 1 | 2011 | 119 | 0.080 |
Why?
|
| Pakistan | 2 | 2020 | 20 | 0.080 |
Why?
|
| Causality | 1 | 2009 | 45 | 0.070 |
Why?
|
| Absorptiometry, Photon | 1 | 2009 | 76 | 0.070 |
Why?
|
| Awareness | 1 | 2009 | 73 | 0.070 |
Why?
|
| Urban Population | 1 | 2011 | 374 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 512 | 0.070 |
Why?
|
| Emergency Service, Hospital | 1 | 2009 | 278 | 0.060 |
Why?
|
| Comorbidity | 1 | 2009 | 737 | 0.060 |
Why?
|
| Young Adult | 3 | 2013 | 5080 | 0.060 |
Why?
|
| Minority Groups | 1 | 2011 | 690 | 0.060 |
Why?
|
| Microsatellite Repeats | 1 | 2004 | 61 | 0.050 |
Why?
|
| Growth | 1 | 2004 | 11 | 0.050 |
Why?
|
| Mass Screening | 1 | 2009 | 541 | 0.050 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2004 | 92 | 0.050 |
Why?
|
| Body Height | 1 | 2004 | 53 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2004 | 92 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 201 | 0.050 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2022 | 20 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2022 | 138 | 0.040 |
Why?
|
| Physicians | 1 | 2004 | 188 | 0.040 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 3156 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 213 | 0.040 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2020 | 13 | 0.040 |
Why?
|
| Halogenation | 1 | 2020 | 19 | 0.040 |
Why?
|
| Genomics | 1 | 2022 | 293 | 0.040 |
Why?
|
| ras Proteins | 1 | 2020 | 54 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 386 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 1996 | 3 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 2017 | 62 | 0.030 |
Why?
|
| Thyroxine | 1 | 1996 | 22 | 0.030 |
Why?
|
| Hypothyroidism | 1 | 1996 | 26 | 0.030 |
Why?
|
| Pharmacists | 1 | 2017 | 61 | 0.030 |
Why?
|
| Logistic Models | 2 | 2013 | 1009 | 0.030 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2016 | 33 | 0.030 |
Why?
|
| Perception | 1 | 2017 | 215 | 0.030 |
Why?
|
| Medicaid | 1 | 2017 | 143 | 0.030 |
Why?
|
| Rural Population | 1 | 2018 | 373 | 0.030 |
Why?
|
| Focus Groups | 1 | 2017 | 423 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2016 | 1604 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 1234 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 153 | 0.030 |
Why?
|
| Prevalence | 1 | 2018 | 1612 | 0.030 |
Why?
|
| Medical Audit | 1 | 2013 | 26 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 2014 | 67 | 0.030 |
Why?
|
| Triglycerides | 1 | 2014 | 147 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2014 | 122 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2013 | 70 | 0.020 |
Why?
|
| Fasting | 1 | 2013 | 56 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2017 | 1600 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1063 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 485 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2014 | 213 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2011 | 34 | 0.020 |
Why?
|
| Obesity, Abdominal | 1 | 2011 | 29 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2011 | 99 | 0.020 |
Why?
|
| Nursing Evaluation Research | 1 | 2011 | 11 | 0.020 |
Why?
|
| Program Development | 1 | 2011 | 240 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2011 | 389 | 0.020 |
Why?
|
| Self Care | 1 | 2011 | 175 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 1857 | 0.020 |
Why?
|
| Phenotype | 1 | 2011 | 780 | 0.020 |
Why?
|
| Health Literacy | 1 | 2011 | 130 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2011 | 574 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 3994 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2011 | 706 | 0.010 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2004 | 14 | 0.010 |
Why?
|
| Tea | 1 | 2004 | 46 | 0.010 |
Why?
|
| Calcium, Dietary | 1 | 2004 | 65 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 989 | 0.010 |
Why?
|
| Alleles | 1 | 2004 | 352 | 0.010 |
Why?
|
| Animals | 1 | 2020 | 16992 | 0.010 |
Why?
|
| HIV Infections | 1 | 1996 | 2586 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2004 | 1759 | 0.010 |
Why?
|
| Exercise | 1 | 2004 | 692 | 0.010 |
Why?
|
| Thyrotropin | 1 | 1996 | 24 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 1996 | 69 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1996 | 1067 | 0.010 |
Why?
|
| Infant | 1 | 1996 | 1175 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1996 | 1546 | 0.010 |
Why?
|